TNF and systemic lupus erythematosus: Our data showed that TNF-α pretreatment further impaired the in vivo homing capacity of SLE BMSCs, indicating that inhibition of the TNF-α pathway may accelerate BMSCs migration to the inflammatory microenvironment in SLE patients, and thereby may have a potential role in the treatment of SLE.